BioXcel Therapeutics (BTAI)
(Delayed Data from NSDQ)
$0.62 USD
-0.02 (-3.18%)
Updated Aug 30, 2024 03:59 PM ET
After-Market: $0.62 +0.01 (0.81%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/12/2024
Time: -- |
9/2024 | $-0.45 | 0.00% |
Earnings Summary
For their last quarter, BioXcel Therapeutics (BTAI) reported earnings of -$0.21 per share, beating the Zacks Consensus Estimate of $-0.76 per share. This reflects a positive earnings surprise of 72.37%. Look out for BTAI's next earnings release expected on November 12, 2024. For the next earning release, we expect the company to report earnings of -$0.45 per share, reflecting a year-over-year increase of 73.84%.
Earnings History
Price & Consensus
Zacks News for BTAI
BioXcel Therapeutics, Inc. (BTAI) Reports Q2 Loss, Tops Revenue Estimates
BTAI: What are Zacks experts saying now?
Zacks Private Portfolio Services